Advanced search
Publication Cover
Climacteric Volume 19, 2016 - Issue 4
Submit an article Journal homepage
17,928
Views
69
CrossRef citations to date
0
Altmetric
Review

The impact of micronized progesterone on the endometrium: a systematic review

P. StuteDepartment of Obstetrics and Gynecology, University of Bern, Switzerland; Correspondence[email protected]
,
J. NeulenClinic for Gynecological Endocrinology and Reproductive Medicine, RWTH University of Aachen, Germany;
&
L. WildtDepartment of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Austria
Pages 316-328 | Received 04 Mar 2016, Accepted 04 May 2016, Published online: 09 Jun 2016

Citations (69)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (16)

Shelli Graham, David F. Archer, James A. Simon, Kathleen M. Ohleth & Brian Bernick. (2022) Review of menopausal hormone therapy with estradiol and progesterone versus other estrogens and progestins. Gynecological Endocrinology 38:11, pages 891-910.
Read now
X. Ruan & A. O. Mueck. (2022) Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view. Climacteric 25:5, pages 443-452.
Read now
Y. Deng, W. Wang, Q. Zheng, Y. Feng, Y. Zou, H. Dong, Z. Tan, X. Zeng, Y. Zhao, D. Peng, X. Yang & A. Sun. (2022) Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?. Climacteric 25:4, pages 413-420.
Read now
Marcio Alexandre Hipolito Rodrigues & Anne Gompel. (2021) Micronized progesterone, progestins, and menopause hormone therapy. Women & Health 61:1, pages 3-14.
Read now
Manuel Luque-Ramírez, Andrés E. Ortiz-Flores, Lia Nattero-Chávez & Héctor F. Escobar-Morreale. (2020) A safety evaluation of current medications for adult women with the polycystic ovarian syndrome not pursuing pregnancy. Expert Opinion on Drug Safety 19:12, pages 1559-1576.
Read now
Miriam Giordano Imbroll & Mark Gruppetta. (2020) A current perspective into young female sex hormone replacement: a review. Expert Review of Endocrinology & Metabolism 15:6, pages 405-414.
Read now
F. Fruzzetti, G. Palla, M. Gambacciani & T. Simoncini. (2020) Tailored hormonal approach in women with premature ovarian insufficiency. Climacteric 23:1, pages 3-8.
Read now
Hanbi Wang, Meizhi Liu, Qiang Fu & Chengyan Deng. (2019) Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study. Drug Design, Development and Therapy 13, pages 2475-2482.
Read now
A. O. Mueck & X. Ruan. (2019) Will estradiol/progesterone capsules for oral use become the best choice for menopausal hormone therapy?. Climacteric 22:6, pages 535-537.
Read now
D. A. Davey. (2018) Menopausal hormone therapy: a better and safer future. Climacteric 21:5, pages 454-461.
Read now
P. Piette. (2018) The history of natural progesterone, the never-ending story. Climacteric 21:4, pages 308-314.
Read now
S. Mirkin. (2018) Evidence on the use of progesterone in menopausal hormone therapy. Climacteric 21:4, pages 346-354.
Read now
A. Gompel. (2018) Progesterone, progestins and the endometrium in perimenopause and in menopausal hormone therapy. Climacteric 21:4, pages 321-325.
Read now
P. Stute, L. Wildt & J. Neulen. (2018) The impact of micronized progesterone on breast cancer risk: a systematic review. Climacteric 21:2, pages 111-122.
Read now
James H Pickar, David F Archer, Risa Kagan, JoAnn V Pinkerton & Hugh S Taylor. (2017) Safety and benefit considerations for menopausal hormone therapy. Expert Opinion on Drug Safety 16:8, pages 941-954.
Read now
M. L’Hermite. (2017) Custom-compounded bioidentical hormone therapy: why so popular despite potential harm? The case against routine use. Climacteric 20:3, pages 205-211.
Read now

Articles from other publishers (53)

Yue Niu, Hong Liu, Xiufang Li, Junli Zhao, Guimin Hao, Yun Sun, Bo Zhang, Chunxiu Hu, Yingli Lu, Chun’e Ren, Yingying Yuan, Jie Zhang, Yao Lu, Qianqian Wen, Min Guo, Mingxing Sui, Guili Wang, Dingying Zhao, Zi-Jiang Chen & Daimin Wei. (2023) Oral micronized progesterone versus vaginal progesterone for luteal phase support in fresh embryo transfer cycles: a multicenter, randomized, non-inferiority trial. Human Reproduction 38:Supplement_2, pages ii24-ii33.
Crossref
Srirupa Ghosh, Rachel Imrie, James Goadsby & Michael Savvas. (2023) A focus on progestogens in hormone replacement therapy. The Obstetrician & Gynaecologist 25:4, pages 263-271.
Crossref
Elisabeth Lerchbaum. (2023) Postmenopausale Hormonersatztherapie: Anleitung für die Praxis!Postmenopausal hormone replacement therapy: a practical guide!. Journal für Klinische Endokrinologie und Stoffwechsel.
Crossref
Petra Stute, Jo Marsden, Noor Salih & Angelo Cagnacci. (2023) Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice. Maturitas 174, pages 8-13.
Crossref
Şener Gezer, Emre Köle & Lale Aksoy. (2023) Vaginal micronized progesterone versus the levonorgestrel‐releasing intrauterine system for treatment of non‐atypical endometrial hyperplasia: A randomized controlled trial. International Journal of Gynecology & Obstetrics 161:2, pages 661-666.
Crossref
莹莹 范. (2023) Current Status of MHT Treatment for Menopausal Syndrome. Advances in Clinical Medicine 13:04, pages 5396-5400.
Crossref
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin e1 e39 .
. 2023. Frauengesundheit � Frauenmedizin. Frauengesundheit � Frauenmedizin 19 58 .
Petra Stute & Serena Lozza-Fiacco. (2022) Strategies to cope with stress and anxiety during the menopausal transition. Maturitas 166, pages 1-13.
Crossref
Petra Stute. (2022) Kombinierte Hormonersatztherapie mit vaginalem Progesteron – ausreichend für den Endometriumschutz?Combination hormone replacement therapy with vaginal progesterone: is it sufficient for endometrial protection?. Gynäkologische Endokrinologie 20:4, pages 282-284.
Crossref
Silvia Federici, Giovanni Goggi, Richard Quinton, Luca Giovanelli, Luca Persani, Biagio Cangiano & Marco Bonomi. (2022) New and Consolidated Therapeutic Options for Pubertal Induction in Hypogonadism: In-depth Review of the Literature. Endocrine Reviews 43:5, pages 824-851.
Crossref
. (2022) The 2022 hormone therapy position statement of The North American Menopause Society. Menopause 29:7, pages 767-794.
Crossref
Xiangyan Ruan & Alfred O. Mueck. (2022) Optimizing menopausal hormone therapy: for treatment and prevention, menstrual regulation, and reduction of possible risks. Global Health Journal 6:2, pages 61-69.
Crossref
Maria Alejandra Belardo, Pisula Pedro & Capalbo Olivia. (2022) Breast cancer and progestins in menopausal hormone therapy: a literature review. Obstetrics & Gynecology International Journal 13:2, pages 101-110.
Crossref
Haitham Hamoda. (2021) British Menopause Society tools for clinicians: Progestogens and endometrial protection. Post Reproductive Health 28:1, pages 40-46.
Crossref
Silvia Federici, Giovanni Goggi, Luca Giovanelli, Biagio Cangiano, Luca Persani, Marco Bonomi & Richard Quinton. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 75 93 .
Alexander Römmler. 2022. Präventionsmedizin und Anti-Aging-Medizin. Präventionsmedizin und Anti-Aging-Medizin 141 166 .
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment 87 103 .
Hilde LöfqvistHilde Löfqvist. 2022. Modern Menopausal Hormone Treatment. Modern Menopausal Hormone Treatment 27 45 .
Patricia Geraghty. 2022. Each Woman’s Menopause: An Evidence Based Resource. Each Woman’s Menopause: An Evidence Based Resource 121 143 .
Eleni Armeni, Stavroula A. Paschou, Dimitrios G. Goulis & Irene Lambrinoudaki. (2021) Hormone therapy regimens for managing the menopause and premature ovarian insufficiency. Best Practice & Research Clinical Endocrinology & Metabolism 35:6, pages 101561.
Crossref
Valerie A Flores, Lubna Pal & JoAnn E Manson. (2021) Hormone Therapy in Menopause: Concepts, Controversies, and Approach to Treatment. Endocrine Reviews 42:6, pages 720-752.
Crossref
Andrew M. Kaunitz, Ekta Kapoor & Stephanie Faubion. (2021) Treatment of Women After Bilateral Salpingo-oophorectomy Performed Prior to Natural Menopause. JAMA 326:14, pages 1429.
Crossref
Nikki Noble. (2021) Hormone replacement therapy: update and practical prescribing. Independent Nurse 2021:10, pages 20-26.
Crossref
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Directive clinique no 422a : Ménopause : symptômes vasomoteurs, agents thérapeutiques d'ordonnance, médecines douces et complémentaires, nutrition et mode de vie. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1205-1223.e1.
Crossref
Nese Yuksel, Debra Evaniuk, Lina Huang, Unjali Malhotra, Jennifer Blake, Wendy Wolfman & Michel Fortier. (2021) Guideline No. 422a: Menopause: Vasomotor Symptoms, Prescription Therapeutic Agents, Complementary and Alternative Medicine, Nutrition, and Lifestyle. Journal of Obstetrics and Gynaecology Canada 43:10, pages 1188-1204.e1.
Crossref
Salwa Abdullahi Idle, Nick Panay & Haitham Hamoda. (2021) A cross-sectional national questionnaire survey assessing the views of members of the British Menopause Society on the management of patients with unscheduled bleeding on hormone replacement therapy. Post Reproductive Health 27:3, pages 159-165.
Crossref
Ursula Gobrecht-Keller. (2021) Gestagengabe in der Menopause: Was sind Unterschiede, Vorteile und Nachteile der einzelnen Präparate?Administration de progestatifs dans la ménopause: différences, avantages et inconvénients des différentes préparations. Journal für Gynäkologische Endokrinologie/Schweiz 24:2, pages 58-68.
Crossref
A. Gosset, G. Robin, B. Letombe, J.-M. Pouillès & F. Trémollieres. (2021) Le traitement hormonal de la ménopause en pratique. RPC Les femmes ménopausées du CNGOF et du GEMVi. Gynécologie Obstétrique Fertilité & Sénologie  49:5, pages 358-372.
Crossref
Nikki Noble. (2021) Hormone replacement therapy: update and practical prescribing. Practice Nursing 32:4, pages 148-156.
Crossref
Riley Bove, Annette Okai, Maria Houtchens, Birte Elias-Hamp, Alessandra Lugaresi, Kerstin Hellwig & Eva Kubala Havrdová. (2021) Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review. Frontiers in Neurology 12.
Crossref
You Xu, Aneesh Thakur, Yibang Zhang & Camilla Foged. (2021) Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects. Pharmaceutics 13:2, pages 177.
Crossref
Anne Gompel. (2020) Progesterone and endometrial cancer. Best Practice & Research Clinical Obstetrics & Gynaecology 69, pages 95-107.
Crossref
Steven E. Conklin & Claire E. Knezevic. (2020) Advancements in the gold standard: Measuring steroid sex hormones by mass spectrometry. Clinical Biochemistry 82, pages 21-32.
Crossref
Manuela Cristina Russu. 2020. Hormone Therapy and Replacement in Cancer and Aging-related Diseases. Hormone Therapy and Replacement in Cancer and Aging-related Diseases.
Kerstin Blickenstorfer. (2020) Vorteile bioidentischer Sexualhormone in der systemischen menopausalen HormontherapieAdvantages of bioidentical hormones in menopausal hormone replacement. Journal für Gynäkologische Endokrinologie/Österreich 30:2, pages 59-63.
Crossref
Nikki Noble. (2020) Hormone replacement therapy: update and practical prescribing. Journal of Prescribing Practice 2:2, pages 91-97.
Crossref
Kerstin Blickenstorfer. (2019) Vorteile bioidentischer Sexualhormone in der systemischen menopausalen HormontherapieAdvantages of bioidentical hormones in menopausal hormone replacement. Gynäkologische Endokrinologie 18:1, pages 31-34.
Crossref
Katrine Yare & Michael Woodward. (2020) Hormone Therapy and Effects on Sporadic Alzheimer’s Disease in Postmenopausal Women: Importance of Nomenclature. Journal of Alzheimer's Disease 73:1, pages 23-37.
Crossref
Tori Hudson & Joseph Katzinger. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine 1549 1569.e5 .
Angelo Cagnacci & Martina Venier. (2019) The Controversial History of Hormone Replacement Therapy. Medicina 55:9, pages 602.
Crossref
Alfred O. Mueck & Thomas Römer. (2019) Choice of progestogen for endometrial protection in combination with transdermal estradiol in menopausal women. Hormone Molecular Biology and Clinical Investigation 37:2.
Crossref
Rafael Sánchez-Borrego, Plácido Llaneza Coto, Nicolás Mendoza Ladrón de Guevara, Rafael Comino Delgado, Javier Ferrer Barriendos, Laura Baquedano Mainar, Ana Rosa Jurado López, Montserrat Manubens, Borja Otero García-Ramos, Daniel Mª Lubián López, Pluvio Jesús Coronado Martín, María Jesús Cancelo Hidalgo, Joaquín Calaf Alsina & Santiago Palacios. (2019) Posicionamiento AEEM-SEGO sobre la terapia hormonal de la menopausia. Progresos de Obstetricia y Ginecología.
Crossref
Ya. Z. Zaidieva. (2019) The effect of progesterone, progestins, and menopausal hormone therapy on the endometrium in peri- and postmenopause. Rossiiskii vestnik akushera-ginekologa 19:2, pages 57.
Crossref
Santiago Palacios, John C Stevenson, Katrin Schaudig, Monika Lukasiewicz & Alessandra Graziottin. (2019) Hormone therapy for first-line management of menopausal symptoms: Practical recommendations. Women's Health 15, pages 174550651986400.
Crossref
Vincenzina Bruni & Francesca Pampaloni. 2019. Menstrual Cycle Related Disorders. Menstrual Cycle Related Disorders 111 142 .
. (2018) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 25:11, pages 1362-1387.
Crossref
Alexander Römmler. (2017) Bioidentische Hormone in der MenopausetherapieHormones bio-identiques dans le traitement de la ménopause. Journal für Gynäkologische Endokrinologie/Schweiz 20:3, pages 102-108.
Crossref
Alexander Römmler. (2017) Bioidentische Hormone in der MenopausetherapieBioidentical hormones in menopausal therapy. Journal für Gynäkologische Endokrinologie/Österreich 27:3, pages 95-101.
Crossref
. (2017) The 2017 hormone therapy position statement of The North American Menopause Society. Menopause 24:7, pages 728-753.
Crossref
John Eden. (2017) The endometrial and breast safety of menopausal hormone therapy containing micronised progesterone: A short review. Australian and New Zealand Journal of Obstetrics and Gynaecology 57:1, pages 12-15.
Crossref
Alfred O. Mueck. (2017) Transdermales Östradiol und ProgesteronTransdermal estradiol and progesterone. Gynäkologische Endokrinologie 15:1, pages 65-72.
Crossref
Petra Stute. (2016) Progesteron und EndometriumsicherheitProgesterone and endometrial safety. Gynäkologische Endokrinologie 14:3, pages 222-222.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.